Sep 14, 20254:20 PM4:30 PMOral CommunicationAPOB-48 SHOWS POTENTIAL AS A BIOMARKER TO EVALUATE TREATMENT RESPONSE WITH APRAGLUTIDE IN SHORT BOWEL SYNDROME, INTESTINAL FAILURE AND COLON-IN-CONTINUITY Astrid VERBIEST
Sep 16, 20258:40 AM8:50 AMOral CommunicationIMPROVED COLONIC PERMEABILITY WITH THE NOVEL, LONG-ACTING GLP-2 ANALOG APRAGLUTIDE IN SHORT BOWEL SYNDROME WITH CHRONIC INTESTINAL FAILUREAstrid VERBIEST